AbbVie, Inc.
(NYSE : ABBV)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Bitcoin & Crypto Movers
Receive our Bitcoin / Cryptocurrency Reports, Free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Major
symbolcompany%chnglast%shortavg$volume
JNJJohnson & Johnson
1.25%130.760.6%$1778.33m
PFEPfizer Inc.
-0.43%42.930.9%$1032.94m
MRKMerck & Co., Inc.
-0.63%74.760.6%$1001.56m
BMYBristol-Myers Squibb Company
1.17%51.521.4%$497.41m
LLYEli Lilly and Company
-0.13%108.221.0%$493.86m
ABBVAbbVie, Inc.
-0.05%84.892.2%$489.04m
NVSNovartis AG Sponsored ADR
-0.13%85.650.2%$228.06m
AZNAstraZeneca PLC Sponsored ADR
0.44%38.521.3%$189.77m
GSKGlaxoSmithKline plc Sponsored ADR
0.45%37.240.2%$155.19m
NVONovo Nordisk A/S Sponsored ADR Class B
-0.59%45.920.1%$77.03m
SNYSanofi Sponsored ADR
-0.41%43.400.2%$45.65m
LCILannett Company, Inc.
0.66%4.5937.0%$7.78m
EPIXESSA Pharma Inc
0.00%2.450.1%$0.00m

Company Profile

AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the discovery, development, manufacture and sale of a line of proprietary pharmaceutical products. It is focused on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology and dermatology; oncology, including blood cancers; virology, including hepatitis C and human immunodeficiency virus; neurological disorders, such as Parkinson's disease; metabolic diseases, including thyroid disease and complications associated with cystic fibrosis; as well as other serious health conditions. The company was founded on January 1, 2013 and is headquartered in North Chicago, IL.